Literature DB >> 31566974

Surface Inhomogeneity of Graphene Oxide Influences Dissociation of Aβ16-21 Peptide Assembly.

Zhi He, Jingyuan Li, Serena H Chen1, Ruhong Zhou1.   

Abstract

Abnormal peptide assembly and aggregation is associated with an array of neurodegenerative diseases including Alzheimer's disease (AD). A detailed understanding of how nanostructured materials such as oxidized graphene perturb the peptide assembly and subsequently induce fibril dissociation may open new directions for the development of potential AD treatments. Here, we investigate the impact of surface inhomogeneity of graphene oxide (GO) on the assembly of amyloid-beta Aβ16-21 peptides on GO surfaces with different degrees of oxidation using molecular dynamics simulations. Interestingly, nonuniform GO nanosheets (in terms of oxidation sites) have a much stronger perturbation effect on the structure of Aβ16-21 assembly. The Aβ peptides exhibit a remarkable tendency in binding to the scattered interfaces between unoxidized and oxidized regions, which induces the dissociation of Aβ amyloid fibril. These findings should deepen our understanding of surface-induced peptide dissociation and stimulate discovery of alternative AD treatments.

Entities:  

Year:  2019        PMID: 31566974     DOI: 10.1021/acs.jpcb.9b07359

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  3 in total

1.  Amyloid-β (Aβ42) Peptide Aggregation Rate and Mechanism on Surfaces with Widely Varied Properties: Insights from Brownian Dynamics Simulations.

Authors:  Timothy Cholko; Joseph Barnum; Chia-En A Chang
Journal:  J Phys Chem B       Date:  2020-06-26       Impact factor: 2.991

Review 2.  Understanding interactions between biomolecules and two-dimensional nanomaterials using in silico microscopes.

Authors:  Serena H Chen; David R Bell; Binquan Luan
Journal:  Adv Drug Deliv Rev       Date:  2022-05-19       Impact factor: 17.873

3.  Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.

Authors:  Kaixuan Wang; Lingfeng Wang; Ling Chen; Chiwei Peng; Beijiao Luo; Jingxin Mo; Wei Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.